These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8611434)

  • 1. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
    Bramhall SR; Stamp GW; Dunn J; Lemoine NR; Neoptolemos JP
    Br J Cancer; 1996 Apr; 73(8):972-8. PubMed ID: 8611434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.
    Polette M; Clavel C; Cockett M; Girod de Bentzmann S; Murphy G; Birembaut P
    Invasion Metastasis; 1993; 13(1):31-7. PubMed ID: 8407209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is determination of matrix metalloproteinases and their tissue inhibitors serum concentrations useful in patients with gastroenteropancreatic and bronchopulmonary neuroendocrine neoplasms?
    Blicharz-Dorniak J; Kos-Kudła B; Foltyn W; Kajdaniuk D; Marek B; Zemczak A; Strzelczyk J
    Endokrynol Pol; 2012; 63(6):470-6. PubMed ID: 23339005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.
    Bramhall SR; Neoptolemos JP; Stamp GW; Lemoine NR
    J Pathol; 1997 Jul; 182(3):347-55. PubMed ID: 9349239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of matrix metalloproteinases in bile duct cancer tissue.
    Sakai T
    Kurume Med J; 2004; 51(3-4):215-23. PubMed ID: 15682828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis.
    Théret N; Musso O; Campion JP; Turlin B; Loréal O; L'Helgoualc'h A; Clément B
    Int J Cancer; 1997 Aug; 74(4):426-32. PubMed ID: 9291433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
    J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
    Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromelysin, gelatinase A and TIMP-1 in prosthetic interface tissue: a role for macrophages in tissue remodelling.
    Hembry RM; Bagga MR; Reynolds JJ; Hamblen DL
    Histopathology; 1995 Aug; 27(2):149-59. PubMed ID: 8835263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.
    Ogata T; Shibamura H; Tromp G; Sinha M; Goddard KA; Sakalihasan N; Limet R; MacKean GL; Arthur C; Sueda T; Land S; Kuivaniemi H
    J Vasc Surg; 2005 Jun; 41(6):1036-42. PubMed ID: 15944607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.
    Bord S; Horner A; Hembry RM; Reynolds JJ; Compston JE
    J Anat; 1997 Jul; 191 ( Pt 1)(Pt 1):39-48. PubMed ID: 9279657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
    Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
    BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis.
    Boor PPC; Sideras K; Biermann K; Hosein Aziz M; Levink IJM; Mancham S; Erler NS; Tang X; van Eijck CH; Bruno MJ; Sprengers D; Zang X; Kwekkeboom J
    Br J Cancer; 2020 Apr; 122(8):1211-1218. PubMed ID: 32071413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.
    Nakopoulou L; Giannopoulou I; Lazaris ACh; Alexandrou P; Tsirmpa I; Markaki S; Panayotopoulou E; Keramopoulos A
    APMIS; 2003 Nov; 111(11):1027-36. PubMed ID: 14629269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.